Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated With Daratumumab Monotherapy
Version 2 2021-01-25, 15:36Version 2 2021-01-25, 15:36
Version 1 2021-01-07, 10:49Version 1 2021-01-07, 10:49
figure
posted on 2021-01-25, 15:36authored byAdis journals on behalf of, Ajai Chari, Markus Munder, Katja Weisel, Matthew Jenner, Ceri Bygrave, Maria Teresa Petrucci, Mario Boccadoro, Michele Cavo, Niels W.C.J. van de Donk, Mehmet Turgut, Fatih Demirkan, Ihsan Karadogan, Edward Libby, Robert Kleiman, Steven Kuppens, Rajesh Bandekar, Tobias Neff, Christoph Heuck, Ming Qi, Pamela L. Clemen, Hartmut Goldschmidt
Article full
text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).